ASCO Immunotherapy Alert: BioMedTracker’s Top Abstract Picks
With cancer checkpoint inhibitors extremely high on the radar at the upcoming American Society of Clinical Oncology annual meeting, BioMedTracker analysts identify the most compelling immunotherapy abstracts.